Credit Agricole’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-21,056
Closed -$301K 1569
2014
Q3
$301K Sell
21,056
-500
-2% -$7.19K ﹤0.01% 1299
2014
Q2
$323K Buy
+21,556
New +$260K ﹤0.01% 1315

Other funds holding AVDL

Credit Agricole's AVDL Position: Q4 2014 in Review

Credit Agricole sold out of Avadel Pharmaceuticals (AVDL) in Q4 2014, closing a stake of 21,056 shares — an estimated $301K sold.

Credit Agricole first reported a position in AVDL in Q2 2014 and held it in 2 quarters. The position peaked at $323K in Q2 2014. 94 funds tracked by Wall St. Rank hold AVDL as of Q4 2014.

  • Credit Agricole reported no remaining Avadel Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Credit Agricole sold 21,056 Avadel Pharmaceuticals shares in Q4 2014, an estimated $301K.
  • Credit Agricole first reported a position in Avadel Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Credit Agricole's Avadel Pharmaceuticals position peaked at $323K in Q2 2014.
  • 94 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2014.

Based on Credit Agricole's 13F filing for Q4 2014, filed 9 Feb 2015.